Xiao-Yun Zhao

5PUBLICATIONS
15CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2023
The Atypical MAP Kinase MAPK15 Is Required for Lung Adenocarcinoma Metastasis via Its Interaction with NF-κB p50 Subunit and Transcriptional Regulation of Prostaglandin E2 Receptor EP3 Subtype.

Fei-Yuan Yu, Qian Xu, Xiao-Yun Zhao

|Jan 08, 2023
Effects of CYP3A43 Expression on Cell Proliferation and Migration of Lung Adenocarcinoma and Its Clinical Significance.

Qi-Yao Wei, Andy T Y Lau, Hai-Ying Mo

|Jul 27, 2022
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway.

Hai-Ying Mo, Qi-Yao Wei, Qiu-Hua Zhong

|Jan 23, 2022
ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes.

Fei-Yuan Yu, Qian Xu, Qi-Yao Wei

|Apr 25, 2020
Resveratrol Promotes Tumor Microvessel Growth via Endoglin and Extracellular Signal-Regulated Kinase Signaling Pathway and Enhances the Anticancer Efficacy of Gemcitabine against Lung Cancer.

San-Hai Qin, Andy T Y Lau, Zhan-Ling Liang

Pageof 1

Frequent Collaborators

5 joint publications

Andy T Y Lau

5 joint publications

Qiu-Hua Zhong

5 joint publications

Yan-Ming Xu

4 joint publications

Hai-Ying Mo